0001918979-22-000001.txt : 20220328 0001918979-22-000001.hdr.sgml : 20220328 20220328100354 ACCESSION NUMBER: 0001918979-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 EFFECTIVENESS DATE: 20220328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aldebaran Therapeutics, Inc. CENTRAL INDEX KEY: 0001918979 IRS NUMBER: 874756963 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-439130 FILM NUMBER: 22773530 BUSINESS ADDRESS: STREET 1: 275 SECOND AVE STREET 2: STE. 200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-203-7118 MAIL ADDRESS: STREET 1: 275 SECOND AVE STREET 2: STE. 200 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001918979 Aldebaran Therapeutics, Inc. 275 SECOND AVE STE. 200 WALTHAM MA MASSACHUSETTS 02451 617-203-7118 DELAWARE None None Corporation true 2022 Carlos Loya c/o Aldebaran Therapeutics, Inc. 275 Second Ave, Suite 200 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Chris Pacheco c/o Aldebaran Therapeutics, Inc. 275 Second Ave, Suite 200 Waltham MA MASSACHUSETTS 02451 Director Lauren Mifflin c/o Aldebaran Therapeutics, Inc. 275 Second Ave, Suite 200 Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2022-02-09 false true false 0 1200000 800000 400000 false 20 0 0 150000 true false Aldebaran Therapeutics, Inc. /s/ Carlos Loya Carlos Loya President 2022-03-27